Search details
1.
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia.
Haematologica
; 108(5): 1272-1283, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36700399
2.
Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.
Pediatr Blood Cancer
; 70(6): e30335, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37036306
3.
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.
Blood
; 125(3): 516-24, 2015 Jan 15.
Article
in English
| MEDLINE | ID: mdl-25395418
4.
The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment.
Haematologica
; 106(8): 2242-2245, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-33626861
5.
Targeting oncogenic Ras signaling in hematologic malignancies.
Blood
; 120(17): 3397-406, 2012 Oct 25.
Article
in English
| MEDLINE | ID: mdl-22898602
6.
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma.
Res Sq
; 2024 Jan 18.
Article
in English
| MEDLINE | ID: mdl-38313265
7.
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.
Blood
; 117(6): 2022-32, 2011 Feb 10.
Article
in English
| MEDLINE | ID: mdl-21163920
8.
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.
Blood
; 117(16): 4253-61, 2011 Apr 21.
Article
in English
| MEDLINE | ID: mdl-21398220
9.
Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.
Proc Natl Acad Sci U S A
; 107(11): 5106-11, 2010 Mar 16.
Article
in English
| MEDLINE | ID: mdl-20194733
10.
Oncogenic Kras initiates leukemia in hematopoietic stem cells.
PLoS Biol
; 7(3): e59, 2009 Mar 17.
Article
in English
| MEDLINE | ID: mdl-19296721
11.
The sum is greater than the FGFR1 partner.
Cancer Cell
; 5(3): 203-4, 2004 Mar.
Article
in English
| MEDLINE | ID: mdl-15050910
12.
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
Blood Adv
; 5(18): 3587-3591, 2021 09 28.
Article
in English
| MEDLINE | ID: mdl-34464969
13.
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice.
JCI Insight
; 5(21)2020 11 05.
Article
in English
| MEDLINE | ID: mdl-32990679
14.
KIT's ship comes in.
Blood
; 120(13): 2541-2, 2012 Sep 27.
Article
in English
| MEDLINE | ID: mdl-23019203
15.
Targeting Ras in myeloid leukemias.
Clin Cancer Res
; 14(8): 2249-52, 2008 Apr 15.
Article
in English
| MEDLINE | ID: mdl-18413813
16.
Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia.
Cancer Res
; 79(9): 2339-2351, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-30862722
17.
Tissue-Specific Oncogenic Activity of KRASA146T.
Cancer Discov
; 9(6): 738-755, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30952657
18.
A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies.
Cancer Res
; 77(21): 5706-5711, 2017 11 01.
Article
in English
| MEDLINE | ID: mdl-28993414
19.
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.
Nat Commun
; 8(1): 2127, 2017 12 19.
Article
in English
| MEDLINE | ID: mdl-29259179
20.
Congenital leukemia cutis with subsequent development of leukemia.
J Am Acad Dermatol
; 54(2 Suppl): S22-7, 2006 Feb.
Article
in English
| MEDLINE | ID: mdl-16427986